Optimal PD-L1–high cutoff for association with overall survival in patients with urothelial cancer treated with durvalumab monotherapy

BACKGROUND: Studies have indicated that programmed death ligand 1 (PD-L1) expression may have utility as a predictive biomarker in patients with advanced/metastatic urothelial carcinoma (UC). Different immunohistochemical (IHC) assays are in development to assess PD-L1 expression on tumor cells (TCs...

Descripción completa

Detalles Bibliográficos
Autores principales: Zajac, Magdalena, Ye, Jiabu, Mukhopadhyay, Pralay, Jin, Xiaoping, Ben, Yong, Antal, Joyce, Gupta, Ashok K., Rebelatto, Marlon C., Williams, J. Andrew, Walker, Jill
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185603/
https://www.ncbi.nlm.nih.gov/pubmed/32339189
http://dx.doi.org/10.1371/journal.pone.0231936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185603/
https://www.ncbi.nlm.nih.gov/pubmed/32339189
http://dx.doi.org/10.1371/journal.pone.0231936

Ejemplares similares